85 related articles for article (PubMed ID: 24875297)
21. [Prognostic significance of p53, HER-2/neu, Ki-67 and VEGF expression in chondrosarcomas].
Stepanova EV; Kharatishvili TK; Lichinitser MR; Baryshnikov AIu; Solov'ev IuN; Trapeznikov NN
Arkh Patol; 2002; 64(6):9-12. PubMed ID: 12534219
[TBL] [Abstract][Full Text] [Related]
22. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas.
Cajaiba MM; Jianhua Luo ; Goodman MA; Fuhrer KA; Rao UN
Int J Surg Pathol; 2010 Oct; 18(5):319-23. PubMed ID: 20484142
[TBL] [Abstract][Full Text] [Related]
23. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
24. [Expression of stromal cell-derived factor-1 in endometriosis by steroid receptor coactivators on steroid hormone].
Shi X; Xu W; Sun Y; Dai H; Wang X
Zhonghua Fu Chan Ke Za Zhi; 2014 Feb; 49(2):114-9. PubMed ID: 24739643
[TBL] [Abstract][Full Text] [Related]
25. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1.
Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; Wang J; Qi R; Matzuk AJ; Song X; Madoux F; Hodder P; Chase P; Griffin PR; Zhou S; Liao L; Xu J; O'Malley BW
Cancer Res; 2014 Mar; 74(5):1506-1517. PubMed ID: 24390736
[TBL] [Abstract][Full Text] [Related]
26. Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.
Rohira AD; Lonard DM
Biochem Pharmacol; 2017 Sep; 140():1-7. PubMed ID: 28390937
[TBL] [Abstract][Full Text] [Related]
27. Localization and sex-difference of steroid receptor coactivator-1 immunoreactivities in the brain of adult female and male mice.
Bian C; Zhang D; Guo Q; Cai W; Zhang J
Steroids; 2011 Feb; 76(3):269-79. PubMed ID: 21145336
[TBL] [Abstract][Full Text] [Related]
28. Review of the in vivo functions of the p160 steroid receptor coactivator family.
Xu J; Li Q
Mol Endocrinol; 2003 Sep; 17(9):1681-92. PubMed ID: 12805412
[TBL] [Abstract][Full Text] [Related]
29. Identification of verrucarin a as a potent and selective steroid receptor coactivator-3 small molecule inhibitor.
Yan F; Yu Y; Chow DC; Palzkill T; Madoux F; Hodder P; Chase P; Griffin PR; O'Malley BW; Lonard DM
PLoS One; 2014; 9(4):e95243. PubMed ID: 24743578
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.
Wang L; Yu Y; Chow DC; Yan F; Hsu CC; Stossi F; Mancini MA; Palzkill T; Liao L; Zhou S; Xu J; Lonard DM; O'Malley BW
Cancer Cell; 2015 Aug; 28(2):240-52. PubMed ID: 26267537
[TBL] [Abstract][Full Text] [Related]
31. Clear cell chondrosarcoma of bone. A report of three cases with immunohistochemical and affinity histochemical observations.
Wang LT; Liu TC
Pathol Res Pract; 1993 May; 189(4):411-5. PubMed ID: 8351242
[TBL] [Abstract][Full Text] [Related]
32. Hierarchical clustering of flow cytometry data for the study of conventional central chondrosarcoma.
Diaz-Romero J; Romeo S; Bovée JV; Hogendoorn PC; Heini PF; Mainil-Varlet P
J Cell Physiol; 2010 Nov; 225(2):601-11. PubMed ID: 20506378
[TBL] [Abstract][Full Text] [Related]
33. Knockout of SRC-1 and SRC-3 in Mice Decreases Cardiomyocyte Proliferation and Causes a Noncompaction Cardiomyopathy Phenotype.
Chen X; Qin L; Liu Z; Liao L; Martin JF; Xu J
Int J Biol Sci; 2015; 11(9):1056-72. PubMed ID: 26221073
[TBL] [Abstract][Full Text] [Related]
34. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma.
Gomez-Brouchet A; Mourcin F; Gourraud PA; Bouvier C; De Pinieux G; Le Guelec S; Brousset P; Delisle MB; Schiff C
Hum Pathol; 2010 Sep; 41(9):1220-30. PubMed ID: 20399482
[TBL] [Abstract][Full Text] [Related]
35. Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary.
Meijer OC; Steenbergen PJ; De Kloet ER
Endocrinology; 2000 Jun; 141(6):2192-9. PubMed ID: 10830308
[TBL] [Abstract][Full Text] [Related]
36. Regional specific regulation of steroid receptor coactivator-1 immunoreactivity by orchidectomy in the brain of adult male mice.
Bian C; Zhang K; Zhao Y; Guo Q; Cai W; Zhang J
Steroids; 2014 Oct; 88():7-14. PubMed ID: 24945110
[TBL] [Abstract][Full Text] [Related]
37. Characterization of CXCR4 expression in chondrosarcoma of bone.
Bai S; Wang D; Klein MJ; Siegal GP
Arch Pathol Lab Med; 2011 Jun; 135(6):753-8. PubMed ID: 21631268
[TBL] [Abstract][Full Text] [Related]
38. The expression of selected immunocytochemical diagnostic markers in the case of chondrosarcoma with a mesenchymal component.
Rzeszutko W; Dziegiel P; Rzeszutko M; Wojnar A
Folia Morphol (Warsz); 2003 Nov; 62(4):513-5. PubMed ID: 14655155
[TBL] [Abstract][Full Text] [Related]
39. Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome.
Rizzo M; Ghert MA; Harrelson JM; Scully SP
Clin Orthop Relat Res; 2001 Oct; (391):224-33. PubMed ID: 11603673
[TBL] [Abstract][Full Text] [Related]
40. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
